Corporation Commitments to Increase US Manufacturing

Abbott Laboratories said in a statement Wednesday that a $500 million investment in manufacturing, research and development capabilities at plants in Illinois and Texas will “go live” by the end of the year.

Apple in February said that it’s committed to spending more than $500 billion on expanding its U.S. manufacturing capabilities over four years.

Randolph, New Jersey-based toy company Cra-Z-Art in March said it is growing its U.S. production capacity by 50%, “to combat the cost of tariffs for imported goods from China and other countries.”

Johnson & Johnson is planning to invest more than $55 billion in new U.S. manufacturing facilities over four years. The investment represents a 25% increase compared with the previous four years, the health care company said in March.

Honda Motor this week said it is moving production of its Civic Hybrid Hatchback from Japan to the U.S., in the face of a barrage of tariffs by the Trump administration, including a 25% tariff on vehicles and auto parts imported into the U.S.

Hyundai in March announced a $21 billion commitment to investing in domestic manufacturing from 2025 to 2028.

As part of that commitment, the company has pledged to put $9 billion toward expanding domestic automobile production to 1.2 million vehicles a year, it said.

Last week, American chip maker Nvidia announced that for this first time in the company’s history, it will be manufacturing chips and AI supercomputers in the U.S.

Taiwanese semiconductor maker TSMC in March announced a $165 billion total investment in U.S. manufacturing capabilities. The investment augments an existing $65 billion investment in semiconductor manufacturing operations in Phoenix by $100 billion. The expansion includes plans for three new plants, two advanced packaging facilities and a major research and development center, the company said.

https://www.cbs17.com/business/ap-business/ap-swiss-pharmaceuticals-company-roche-announces-50b-investment-in-us-over-next-5-years/
Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.

4 Likes